Results 201 to 210 of about 710,167 (255)

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology [PDF]

open access: yesCurrent Neuropharmacology, 2013
Acetylcholinesterase is involved in the termination of impulse transmission by rapid hydrolysis of the neurotransmitter acetylcholine in numerous cholinergic pathways in the central and peripheral nervous systems. The enzyme inactivation, induced by various inhibitors, leads to acetylcholine accumulation, hyperstimulation of nicotinic and muscarinic ...
Mirjana B. Čolović   +2 more
exaly   +5 more sources

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in Their Pathogenesis [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Acetylcholinesterase (AChE) plays an important role in the pathogenesis of neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative stress and aggregation of pathological proteins. There is a search for new compounds that can prevent the occurrence of neurodegenerative diseases and slow down their course.
Mariola Herbet, Lucja Justyna Walczak
exaly   +3 more sources

Acetylcholinesterase inhibitors in MG: To be or not to be?

Muscle & Nerve, 2009
Abstract Myasthenia gravis (MG) is an autoimmune disorder usually caused by antibodies against either the acetylcholine receptor (AChR) or muscle‐specific tyrosine kinase (MuSK) at the neuromuscular junction. Neuromuscular transmission failure results in muscle fatigue and weakness that can be treated symptomatically with ...
Anna Rostedt, Punga, Erik, Stålberg
openaire   +2 more sources

Aminopyridazines as Acetylcholinesterase Inhibitors

Journal of Medicinal Chemistry, 1999
Following the discovery of the weak, competitive and reversible acetylcholinesterase (AChE)-inhibiting activity of minaprine (3c) (IC50 = 85 microM on homogenized rat striatum AChE), a series of 3-amino-6-phenylpyridazines was synthesized and tested for inhibition of AChE.
J M, Contreras   +4 more
openaire   +2 more sources

Flavonoids as Acetylcholinesterase Inhibitors

Current Medicinal Chemistry, 2011
Flavonoids are new promising potential natural compounds for treating Alzheimer's disease (AD). Actually most promising drugs for symptomatic treatment of AD are acetylcholinesterase inhibitors (AChEI). Flavonoids with AChE inhibitory activity and due to their well known antioxidant activity could be new multipotent drugs for AD treatment.
I, Uriarte-Pueyo, M I, Calvo
openaire   +2 more sources

Synthesis and activities of acetylcholinesterase inhibitors

Chemical Biology & Drug Design, 2021
AbstractCholinesterase (ChE) inhibitors can be divided into two categories: acetylcholinesterase (AChE) inhibitors and butylcholinesterase (BuChE) inhibitors. Therefore, the development of selective inhibition of AChE and BuChE activities is the central content of ChE pharmacochemistry research.
Shiyang Zhou, Gangliang Huang
openaire   +2 more sources

Puromycin as an inhibitor of acetylcholinesterase

Biochimica et Biophysica Acta (BBA) - Enzymology, 1974
Abstract A kinetic analysis of the interaction of puromycin, an inhibitor of protein synthesis, with bovine red cell acetylcholinesterase (acetylcholine hydrolase, EC 3.1.1.7) shows that puromycin is a reversible mixed inhibitor of this enzyme. Puromycin inhibition is similar to that of the pachycurares, such as d- tubocurarine , and is quite ...
D R, Moss, D E, Moss, D, Fahrney
openaire   +2 more sources

Review of the acetylcholinesterase inhibitor galanthamine

Expert Opinion on Investigational Drugs, 2000
Galanthamine (or galantamine, Reminyl) is a tertiary alkaloid acetylcholinesterase inhibitor (AChEI) which has been approved in several countries for the symptomatic treatment of senile dementia of the Alzheimer's type. Derived from bulbs of the common snowdrop and several Amaryllidaceae plants, (-)-galanthamine (GAL) has long been used in anaesthetics
J J, Sramek   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy